Life Science Archives - Level39

Proposed Placing of new ordinary shares to raise at least £1.5 million

Life Science

NetScientific PLC, the life sciences and sustainability technology investment and commercialisation group, is pleased to announce that the Company is carrying out an equity fundraising to raise at least £1.5 million (the “Placing”), before expenses, via the issue of an …

Read more

Q-Bot Limited (“Q-Bot”) secures £1.6m of investment to fund growth

Fintech
Life Science
Technology

NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group announces that portfolio company Q-Bot has successfully closed a £1.62m investment round to fund the next stage of its growth. The additional funds will allow …

Read more

PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101

Life Science

NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has been granted Fast Track designation for PDS0101 in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® …

Read more

Foxberry expands in Australia with Foxf9 developed BetaShares ETF

Life Science
Sustainability
Technology

London, 2 June 2022 Foxberry Ltd, the provider of financial indices and front-office technology for the financial sector, today announced that BetaShares in Australia has chosen Foxberry as the index provider for its new Future of Food ETF investing in the …

Read more

PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza Vaccine

Life Science
Technology

London, UK – 28 January 2022 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS”), announced yesterday preclinical data for its universal flu vaccine, …

Read more

Q-Bot Investment and Share Acquisition – NetScientific Plc

Life Science

Q-Bot Investment and Share Acquisition NetScientific takes c.19% direct stake in construction industry robotics company Q-Bot and leads Convertible Loan round London, UK – 21 December 2021 – NetScientific plc (AIM:NSCI), the international life sciences and sustainability technology investment and commercialisation Group, …

Read more

EMVC syndicates additional £0.73m investment

Life Science
Technology

Syndication highlights strength of capital light investment model London, UK – 13 December 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that on 9 December 2021 its corporate finance and venture …

Read more

PDS Phase 2 Clinical Trial Update

Life Science

PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination London, UK – 06 December 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group,  announces that its portfolio …

Read more

Sofant Signs €7.3m European Space Agency Contract

Life Science
Technology

London, UK – 4 November 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, Sofant Technologies ("Sofant"), the leading 5G and Satcom antenna developer based in Edinburgh, has …

Read more

EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer Sofant Technologies

Life Science

London, UK – 26 October 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group,  announces that its corporate finance and venture capital division EMV Capital Ltd ("EMVC") advised on a £843k fundraise, made …

Read more